In all cases, the fact that BPC-157 is sold for research purposes only is reflected in the protocols themselves: there is no crossover into clinical recommendations or casual self-experimentation
doi:10.1042/BST20120066
Lu XL, Liu JJ, Li JT, Yang QA, Zhang JM
The benzyl alcohol in bacteriostatic water helps inhibit bacterial growth, extending the refrigerated shelf life
Advantages of structure-based drug design approaches in neurological disorders
Conclusion Prescriptive peptide therapies, including oral BPC-157, larazotide, KPV, and injectable thymosin beta-4, offer a groundbreaking approach to managing chronic conditions like leaky gut syndrome, IBD, celiac recovery, autoimmune diseases, and MCAS